Multiple indirect gene targets via microRNA cargo (miRNA targets)

Multiple indirect gene targets via microRNA (miRNA) cargo refers to the complex network of messenger RNAs regulated by small non-coding RNAs, often delivered via extracellular vesicles or synthetic nanoparticles. Unlike traditional targeted therapies that hit a single receptor or enzyme, a single miRNA can modulate the expression of tens to hundreds of different genes simultaneously by binding to their 3' untranslated regions. This mechanism allows for the coordinated regulation of entire biological pathways, making it a potent strategy for treating multifactorial diseases like cancer and systemic fibrosis. In a therapeutic context, the miRNA itself acts as the drug (mimic) or the drug target (antagomir), while the 'indirect targets' are the downstream mRNAs whose protein products are reduced. This broad regulatory reach provides high efficacy in complex pathologies but also poses significant challenges regarding off-target effects and unpredictable systemic toxicity. Consequently, characterizing the 'targetome' is essential for the clinical development of RNA-based therapeutics to ensure safety and specificity.

Other names

miRNA-targetomeMicroRNA-regulated gene networkDownstream miRNA effectorsExosomal miRNA targets

Drugs such as miRNA mimics or antagomirs modulate the levels of specific microRNAs, which subsequently bind to the 3' untranslated regions (UTRs) of multiple target mRNAs. This binding facilitates the recruitment of the RNA-induced silencing complex (RISC), leading to mRNA degradation or the inhibition of protein translation across a broad network of genes.